<DOC>
	<DOC>NCT02327676</DOC>
	<brief_summary>This study evaluates generic emtricitabine(FTC) in Chinese naive children chronic hepatitis B patients. Single group of child patients were enrolled, which include HBeAg positive and negative Chronic hepatitis B(CHB)group.</brief_summary>
	<brief_title>Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients</brief_title>
	<detailed_description>Generic emtricitabine(FTC) has been approved for treatment of naive chronic hepatitis B(CHB) patients in China. Yet data are limited for this agent in children paitients. The investigators design this trial to test the effect of FTC in Chinese children CHB which including naive HBeAg positive and Negative CHB patients.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>Children with body weight ≥ 33 kg and who can swallow entire emtricitabine capsle(200mg) HBsAg positive for more than 6 months HBeAg positive patients: HBV DNA ≥ 5log10 copies/ml HBeAg positive patients: ALT≥2×ULN;or liver biopsy G≥2;or liver biopsy S ≥2;or liver biopsy Knodell HAI ≥ 4 HBeAg negative patients: HBV DNA ≥ 4log10 copies/ml HBeAg positive patients: ALT≥2×ULN;or liver biopsy G≥2;or liver biopsy S ≥2;or liver biopsy Knodell HAI ≥ 4 Nucleoside/nucleotide naive patients Diagnosed HCC with AFP and ultrasound, CT or MRI Creatine ＞130μmol/L or Ccr &lt; 70mL/min Hemoglobin &lt;100g/L Neutrophils &lt;1.5E+9/L PLT&lt;80E+9/L Coinfected with HAV,HEV,HCV,HDV or HIV ANA ＞ 1:100 Uncontrolled cardiovascular diseases, kidney diseases,lung diseases, neurological diseases, digestive diseases,metabolic disorders, immunecompromised diseases or cancer Drug abuse or alcohol addiction Previous history of taking agents of lamivudine, adefovir, tenofovir entecavir or telbivudine Longterm use of immunosuppressor or immunomodulator 6 months before enrollment to this trial Underwent liver transplantation or liver transplantation in schedule Allergic to nucleoside or nucleotide analogues Pregnancy or in breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Hepatitis B, chronic</keyword>
	<keyword>Emtricitabine</keyword>
	<keyword>Child</keyword>
</DOC>